Clinical Trial Update: A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cediranib for alveolar soft-part sarcoma; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Soft Part Sarcoma

Drugs mentioned

• Cediranib (Cediranib)

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Alveolar Soft-part Sarcoma | Phase 2 | Status: UNKNOWN